|
🐜
|
BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.
10 auth.
Haijuan Yang,
P. Jeffrey,
Julie J. Miller,
E. Kinnucan,
Yutong Sun,
N. Thoma,
...
N. Zheng,
Phang-lang Chen,
Wen-Hwa Lee,
N. Pavletich
|
9 |
2002 |
9
🐜
|
|
🐜
|
Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and Pathways
32 auth.
L. Sang,
Julie J. Miller,
K. Corbit,
R. Giles,
Matthew J. Brauer,
E. Otto,
L. M. Baye,
Xiaohui Wen,
S. Scales,
M. Kwong,
E. Huntzicker,
Mindan K. Sfakianos,
W. Sandoval,
J. Bazan,
Priya Kulkarni,
...
F. Garcia-Gonzalo,
Allen D. Seol,
John F. O'Toole,
Susanne Held,
H. Reutter,
William Arbuthnot Sir Lane,
M. Rafiq,
A. Noor,
M. Ansar,
A. R. R. Devi,
V. Sheffield,
D. Slusarski,
J. Vincent,
D. Doherty,
F. Hildebrandt,
Jeremy F. Reiter,
P. Jackson
|
9 |
2011 |
9
🐜
|
|
🐜
|
Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase.
7 auth.
B. Hao,
N. Zheng,
B. Schulman,
Geng Wu,
Julie J. Miller,
M. Pagano,
...
N. Pavletich
|
8 |
2005 |
8
🐜
|
|
🐜
|
Regulation of Heterochromatic Silencing and Histone H 3 Lysine-9 Methylation by RNAi
8 auth.
P. Jeffrey,
Julie J. Miller,
E. Kinnucan,
N. Thomä,
N. Zheng,
Phang-lang Chen,
...
Wen-Hwa Lee,
N. Pavletich
|
7 |
2002 |
7
🐜
|
|
🦁
|
Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor.
7 auth.
Julie J. Miller,
Matthew K. Summers,
David V. Hansen,
M. Nachury,
N. Lehman,
A. Loktev,
...
P. Jackson
|
7 |
2006 |
7
🦁
|
|
🦁
|
Isocitrate dehydrogenase‐mutant glioma: Evolving clinical and therapeutic implications
Julie J. Miller,
H. Shih,
O. Andronesi,
D. Cahill
|
6 |
2017 |
6
🦁
|
|
🦁
|
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
31 auth.
Julie J. Miller,
L. G. Gonzalez Castro,
S. McBrayer,
M. Weller,
T. Cloughesy,
J. Portnow,
O. Andronesi,
J. Barnholtz-Sloan,
B. Baumert,
M. Berger,
W. Bi,
R. Bindra,
D. Cahill,
Susan M. Chang,
J. Costello,
...
C. Horbinski,
Raymond Y Huang,
R. Jenkins,
K. Ligon,
I. Mellinghoff,
L. Nabors,
M. Plattén,
D. Reardon,
D. Shi,
D. Schiff,
W. Wick,
Hai Yan,
A. von Deimling,
M. J. van den Bent,
W. Kaelin,
P. Wen
|
6 |
2022 |
6
🦁
|
|
🐬
|
High‐throughput generation of tagged stable cell lines for proteomic analysis
J. Torres,
Julie J. Miller,
P. Jackson
|
6 |
2009 |
6
🐬
|
|
🐜
|
Intratumoral heterogeneity and TERT promoter mutations in progressive/higher-grade meningiomas
25 auth.
T. Juratli,
C. Thiede,
Mara V. A. Koerner,
Shilpa S. Tummala,
D. Daubner,
G. Shankar,
E. Williams,
M. Martinez-Lage,
S. Soucek,
K. Robel,
T. Penson,
M. Krause,
S. Appold,
M. Meinhardt,
T. Pinzer,
...
Julie J. Miller,
D. Krex,
Heather A. Ely,
I. Silverman,
J. Christiansen,
G. Schackert,
H. Wakimoto,
M. Kirsch,
P. Brastianos,
D. Cahill
|
6 |
2017 |
6
🐜
|
|
🐢
|
Lower Grade Gliomas
G. Youssef,
Julie J. Miller
|
6 |
2020 |
6
🐢
|
|
🐜
|
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
12 auth.
T. Juratli,
Shilpa S. Tummala,
Angelika Riedl,
D. Daubner,
Silke Hennig,
T. Penson,
...
A. Zolal,
C. Thiede,
G. Schackert,
D. Krex,
Julie J. Miller,
D. Cahill
|
6 |
2018 |
6
🐜
|
